JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M513101200 on December 27, 2005

J. Biol. Chem., Vol. 281, Issue 11, 7189-7196, March 17, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/11/7189    most recent
M513101200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Christmas, P.
Right arrow Articles by Soberman, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Christmas, P.
Right arrow Articles by Soberman, R. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Cytochrome P-450 4F18 Is the Leukotriene B4 {omega}-1/{omega}-2 Hydroxylase in Mouse Polymorphonuclear Leukocytes

IDENTIFICATION AS THE FUNCTIONAL ORTHOLOGUE OF HUMAN POLYMORPHONUCLEAR LEUKOCYTE CYP4F3A IN THE DOWN-REGULATION OF RESPONSES TO LTB4*

Peter Christmas{ddagger}, Karine Tolentino{ddagger}, Valeria Primo{ddagger}, Karin Zemski Berry§, Robert C. Murphy§, Mei Chen, David M. Lee, and Roy J. Soberman{ddagger}1

From the {ddagger}Renal Unit and Department of Medicine, Massachusetts General Hospital (East), Charlestown, Massachusetts 02129, the §Department of Pharmacology, University of Colorado Health Sciences Center, Aurora, Colorado 80045, and the Division of Rheumatology and Immunology, and Allergy, Brigham and Women's Hospital, Boston, Massachusetts 02115

Leukotriene B4 (LTB4) is a potent chemoattractant for polymorphonuclear leukocytes (PMN) and other cells. Human PMN inactivate LTB4 by {omega}-oxidation catalyzed by cytochrome P-450 (CYP) 4F3A. The contribution of the enzymatic inactivation of LTB4 by CYP4Fs to down-regulating functional responses of cells to LTB4 is unknown. To elucidate the role of CYP4F-mediated inactivation of LTB4 in terminating the responses of PMN to LTB4 and to identify a target for future genetic studies in mice, we have identified the enzyme that catalyzes the {omega}-1 and {omega}-2 oxidation of LTB4 in mouse myeloid cells as CYP4F18. As determined by mass spectrometry, this enzyme catalyzes the conversion of LTB4 to 19-OH LTB4 and to a lesser extent 18-OH LTB4. Inhibition of CYP4F18 resulted in a marked increase in calcium flux and a 220% increase in the chemotactic response of mouse PMN to LTB4. CYP4F18 expression was induced in bone marrow-derived dendritic cells by bacterial lipopolysaccharide, a ligand for TLR4, and by poly(I·C), a ligand for TLR3. However, when bone marrow-derived myeloid dendritic cells trafficked to popliteal lymph nodes from paw pads, the expression of CYP4F18 was down-regulated. The results identify CYP4F18 as a critical protein in the regulation of LTB4 metabolism and functional responses in mouse PMN and identify it as the functional orthologue of human PMN CYP4F3A.


Received for publication, December 8, 2005

* This work was supported by National Institutes of Health Grants GM-61823 (to R. J. S.), DK59991 (to P. C.), 5R01HL025785-25 (to R. C. M.), 5R01HL068256-03 (to N. C.), R01HL25785 (to R. C. M.), K08 AR 02214-04 and R01 AI 059746-02 (to D. L.), R03DK067940 and the Patricia Weilder Young Investigator Award from the National Kidney Foundation (to B. N.), and a gift from the Jewish Communal Fund (to R. J. S). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed: Renal Unit and Dept. of Medicine, MA General Hospital (East), Bldg 149, Navy Yard, 13th St., Charlestown, MA 02129. Tel.: 617-726-3747; Fax: 617-726-5669; E-mail: soberman{at}helix.mgh.harvard.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
M. A. Gijon, S. Zarini, and R. C. Murphy
Biosynthesis of eicosanoids and transcellular metabolism of leukotrienes in murine bone marrow cells
J. Lipid Res., March 1, 2007; 48(3): 716 - 725.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.